| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVTY | Common Stock | Options Exercise | $197,438 | +3,750 | +20% | $52.65 | 22,352 | 20 Mar 2023 | Direct | F1 |
| transaction | RVTY | Common Stock | Sale | $1,825 | -15 | -0.07% | $121.69 | 22,337 | 20 Mar 2023 | Direct | F2, F3 |
| transaction | RVTY | Common Stock | Sale | $631,901 | -5,122 | -23% | $123.37 | 17,215 | 20 Mar 2023 | Direct | F2, F4 |
| transaction | RVTY | Common Stock | Sale | $657,749 | -5,304 | -31% | $124.01 | 11,911 | 20 Mar 2023 | Direct | F2, F5 |
| transaction | RVTY | Common Stock | Sale | $37,437 | -300 | -2.5% | $124.79 | 11,611 | 20 Mar 2023 | Direct | F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVTY | NQ Stock Option (right to buy) | Options Exercise | $0 | -3,750 | -100% | $0.000000* | 0 | 20 Mar 2023 | Common Stock | 3,750 | $52.65 | Direct | F1, F7 |
| Id | Content |
|---|---|
| F1 | The Exercise Price included on the Form 4 filed on February 8, 2017 for the Reporting Person was incorrectly reported due to administrative error. |
| F2 | The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Tereau on February 16, 2023. |
| F3 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $121.66 to $121.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F4 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $122.74 to $123.72. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F5 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $123.74 to $124.73. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F6 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $124.74 to $124.81. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F7 | This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted. |
Senior Vice President, Strategy and Business Development